Ушбу иш иқтибос қилган ишлар

236 та иш

Иш: Advancements in risk stratification and management strategies in primary cardiovascular prevention

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén +25
Мақола20172 иқтибос
ABI
A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins
Tetsu Watanabe, Kaoru Ando, Hyuma Daidoji +14
Мақола20172 иқтибос
ABI
Clinical Genetic Testing for Familial Hypercholesterolemia
Amy C. Sturm, Joshua W. Knowles, Samuel S. Gidding +29
Шарҳ мақола20182 иқтибос
ABI
The Forgotten Lipids: Triglycerides, Remnant Cholesterol, and Atherosclerotic Cardiovascular Disease Risk
Pratik B. Sandesara, Salim S. Virani, Sergio Fazio +1
Шарҳ мақола20182 иқтибос
ABI
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis
Francesco Potì, Daniele Santi, Giorgia Spaggiari +2
Шарҳ мақола20192 иқтибос
ABI
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert +15
Шарҳ мақола20192 иқтибос
ABI
Artificial Intelligence in Cardiovascular Imaging
Damini Dey, Piotr J. Slomka, Paul Leeson +4
Шарҳ мақола20192 иқтибос
ABI
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97
Мақола20192 иқтибос
ABI
Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters +22
Мақола20192 иқтибос
ABI
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
Mark Trinder, Gordon A. Francis, Liam R. Brunham
Мақола20202 иқтибос
ABI
Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
Jan Borén, M. John Chapman, Ronald M. Krauss +27
Мақола20202 иқтибос
ABI
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend +8
Мақола20202 иқтибос
ABI
Colchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd +30
Мақола20202 иқтибос
ABI
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia +19
Мақола20202 иқтибос
ABI
Heart Disease and Stroke Statistics—2021 Update
Salim S. Virani, Álvaro Alonso, Hugo J. Aparicio +36
Мақола20212 иқтибос
ABI
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Steven H J Hageman, Lisa Pennells, Francisco Ojeda +97
Мақола20212 иқтибос
ABI
Familial Hypercholesterolemia
Julia Brandts, Kausik K. Ray
Шарҳ мақола20212 иқтибос
ABI
Managing Atherosclerotic Cardiovascular Risk in Young Adults
Neil J. Stone, Sidney C. Smith, Carl E. Orringer +9
Шарҳ мақола20222 иқтибос
ABI
Integrated single-cell analysis-based classification of vascular mononuclear phagocytes in mouse and human atherosclerosis
Alma Zernecke, Florian Erhard, Tobias Weinberger +4
Мақола20222 иқтибос
ABI
New Approaches for Targeting PCSK9: Small-Interfering Ribonucleic Acid and Genome Editing
Reindert F. Oostveen, Amit V. Khera, Sekar Kathiresan +5
Шарҳ мақола20232 иқтибос
ABI
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Ania M. Jastreboff, Lee M. Kaplan, Juan P. Frías +7
Мақола20232 иқтибос
ABI
The Cardiovascular Effect of Tirzepatide: A Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide Dual Agonist
Yun Kyung Cho, Yoo La Lee, Chang Hee Jung
Шарҳ мақола20232 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI